Veeva Systems Inc. $VEEV Shares Acquired by Nellore Capital Management LLC

Nellore Capital Management LLC boosted its holdings in shares of Veeva Systems Inc. (NYSE:VEEV) by 8.3% during the second quarter, Holdings Channel.com reports. The institutional investor owned 484,515 shares of the technology company’s stock after acquiring an additional 37,214 shares during the quarter. Veeva Systems accounts for approximately 9.5% of Nellore Capital Management LLC’s portfolio, making the stock its 5th largest position. Nellore Capital Management LLC’s holdings in Veeva Systems were worth $85,987,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. SHP Wealth Management acquired a new stake in Veeva Systems during the 4th quarter valued at $26,000. MV Capital Management Inc. acquired a new stake in shares of Veeva Systems during the 4th quarter worth about $30,000. Reflection Asset Management bought a new stake in shares of Veeva Systems during the 4th quarter worth about $32,000. BOK Financial Private Wealth Inc. acquired a new position in Veeva Systems in the 4th quarter valued at about $33,000. Finally, Measured Wealth Private Client Group LLC bought a new position in Veeva Systems in the 3rd quarter valued at about $45,000. 88.20% of the stock is currently owned by institutional investors.

Insider Transactions at Veeva Systems

In other Veeva Systems news, insider Thomas D. Schwenger sold 36,000 shares of the business’s stock in a transaction dated Thursday, August 13th. The stock was sold at an average price of $250.23, for a total transaction of $9,008,280.00. Following the completion of the transaction, the insider owned 19,449 shares of the company’s stock, valued at approximately $4,866,723.27. The trade was a 64.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by corporate insiders.

Key Headlines Impacting Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Strong results and outlook support the rally. Veeva’s latest quarterly revenue rose 17.6% year over year to $927.96 million, exceeding estimates of $905.38 million. Adjusted earnings of $2.35 per share also topped the $2.23 consensus estimate. The company raised or maintained forward guidance, including fiscal 2027 EPS guidance of approximately $9.21 and third-quarter guidance of $2.33 to $2.34. Veeva Rises on Sales and Margin Gains, Guidance Raise
• Positive Sentiment: Falcon Safety expands Veeva’s AI-driven product offering. The company launched Veeva Falcon Safety, an agentic safety-operations product designed to automate adverse-event intake, case processing, and follow-up across all E2B-compliant safety systems and intake channels. The product could help biopharmaceutical customers reduce costs, improve processing speed, and maintain regulatory compliance, potentially creating additional growth opportunities. Veeva Falcon Safety to Work with All E2B-Compliant Safety Systems Across Any Intake Channels
• Positive Sentiment: Analyst sentiment has improved. An analyst upgrade helped lift investor confidence, while recent price-target increases—including RBC’s target of $325—reinforce the view that earnings momentum may justify additional upside. Veeva Systems Trading Up After Analyst Upgrade
• Neutral Sentiment: Veeva will present at the Wells Fargo 21st Annual Healthcare Conference. The event may provide updates on strategy and demand, but the announcement itself does not change financial forecasts. Veeva to Present at Upcoming Investor Conferences
• Negative Sentiment: Insider selling creates a modest sentiment risk. Exiting President Thomas Schwenger sold 10,000 shares for roughly $2.8 million, reducing his direct holdings substantially. Because the transaction was made under a pre-arranged Rule 10b5-1 plan, it may reflect scheduled portfolio management rather than a negative view of Veeva’s prospects. Veeva’s Exiting President Sold $2.8 Million in Stock
• Negative Sentiment: Investor Michael Burry also trimmed his Veeva position after the stock nearly doubled, potentially adding short-term selling pressure and highlighting concerns about the shares’ elevated valuation.

Veeva Systems Trading Up 0.7%

Shares of Veeva Systems stock opened at $281.25 on Thursday. The company has a market cap of $45.69 billion, a PE ratio of 46.26, a price-to-earnings-growth ratio of 1.19 and a beta of 0.97. The company has a 50 day moving average of $215.92 and a 200-day moving average of $186.57. Veeva Systems Inc. has a 1-year low of $148.05 and a 1-year high of $310.50.

Veeva Systems (NYSE:VEEV) last announced its quarterly earnings data on Wednesday, August 26th. The technology company reported $2.35 EPS for the quarter, beating the consensus estimate of $2.23 by $0.12. The business had revenue of $927.96 million during the quarter, compared to the consensus estimate of $905.38 million. Veeva Systems had a net margin of 29.34% and a return on equity of 14.25%. The company’s revenue was up 17.6% on a year-over-year basis. During the same period in the previous year, the business earned $1.99 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. Research analysts forecast that Veeva Systems Inc. will post 6.7 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have recently commented on VEEV shares. Zacks Research downgraded Veeva Systems from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 14th. Weiss Ratings raised Veeva Systems from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, August 12th. BNP Paribas Exane reissued an “outperform” rating and set a $285.00 target price on shares of Veeva Systems in a report on Thursday, June 4th. BTIG Research restated a “buy” rating and issued a $340.00 price target on shares of Veeva Systems in a research note on Thursday, June 4th. Finally, Piper Sandler boosted their price objective on shares of Veeva Systems from $295.00 to $320.00 and gave the company an “overweight” rating in a report on Thursday, August 27th. Nineteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $284.46.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.